Cardinal Health vs Cencora
Add, change or remove companies; up to four.
KIRA’s take AI analyst
I put Cardinal Health and Cencora side by side, using each one’s latest annual report. Here is what stands out:
- Cencora is the larger business, with $321.3B of revenue in fiscal 2025 against $254.2B for Cardinal Health.
- Cardinal Health grew revenue faster (14.2%, against 9.3%).
- Cardinal Health turned more of its sales into free cash flow (1.8% FCF margin, against 1.0%).
Who comes out ahead
Of the 9 measures where higher (or lower) is clearly better, how many each company leads.
Cardinal Health
CAH
5/9
Revenue growthGross marginOperating marginNet marginFCF margin
Cencora
COR
4/9
5-year growthPiotroski F-scoreNet debt / EBITDAShare count change
Side by side
Best in the row
| Latest fiscal year | CAH FY26 | COR FY25 |
|---|---|---|
| Size | ||
| Market cap | $59.6B | $64.0B |
| Revenue | $254.2B | $321.3B |
| Free cash flow | $4.5B | $3.2B |
| Net income | $1.7B | $1.6B |
| Growth | ||
| Revenue growth | 14.2% | 9.3% |
| 5-year growth | 9.4% | 11.1% |
| Share count change | −2.1% | −2.5% |
| Profitability | ||
| Gross margin | 3.8% | 3.6% |
| Operating margin | 1.0% | 0.8% |
| Net margin | 0.7% | 0.5% |
| FCF margin | 1.8% | 1.0% |
| Return on capital | — | — |
| Return on equity | — | — |
| Balance sheet | ||
| Net debt | $4.0B | $3.3B |
| Net debt / EBITDA | 1.1x | 0.9x |
| Dividends and buybacks | $1.8B | $873M |
| Valuation & quality | ||
| P/E | — | 24.5x |
| Piotroski F-score | 6 | 7 |
Ten years
Revenue
Operating margin
Free cash flow
Return on capital
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.